[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Dyne_tx Dyne Therapeutics
Dyne Therapeutics posts on X about has been, japan, $dyn, investment the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX -XX%
- X Month XXXXX +91%
- X Months XXXXXX +5.90%
- X Year XXXXXX -XX%
Mentions: X #
- X Week XX -XX%
- X Month XX -XXXX%
- X Months XX -XX%
- X Year XXX +52%
Followers: XXXXX #
- X Week XXXXX +0.40%
- X Month XXXXX +1.10%
- X Months XXXXX +7.30%
- X Year XXXXX +9.80%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks countries finance
Social topic influence has been, japan, $dyn, investment
Top assets mentioned Dyne Therapeutics, Inc. Common Stock (DYN)
Top Social Posts #
Top posts by engagements in the last XX hours
"DYNE-251 has been granted Orphan Drug designation in Japan for the treatment of patients with #Duchenne muscular dystrophy (#DMD) who have mutations in the DMD gene that are amenable to exon XX skipping. Read here:"
X Link @Dyne_tx 2025-09-29T12:47Z 1250 followers, XXX engagements
"Were pleased to share new positive data from our Phase 1/2 DELIVER trial of DYNE-251 in DMD at the @MDAorg Conference. Learn more: $DYN"
X Link @Dyne_tx 2025-03-17T11:45Z 1250 followers, XXX engagements
"Sarahs family lives with #DM1 across generations. On #MytonicDystrophy Awareness Day we share her story and journey with DM1. Watch the full video:"
X Link @Dyne_tx 2025-09-15T13:56Z 1251 followers, XXX engagements
"Today we mark the 5th Annual International #MyotonicDystrophy Awareness Day. At Dyne were honored to be a member of the Global Alliance for Myotonic Dystrophy to help raise awareness and advance research. Learn more:"
X Link @Dyne_tx 2025-09-15T17:31Z 1248 followers, XXX engagements
"Data from the ongoing Phase 1/2 ACHIEVE trial in DM1 to be presented at the Congress of the @WorldMuscleSoc continue to demonstrate a favorable safety and efficacy profile for zeleciment basivarsen (formerly known as DYNE-101). See the data:"
X Link @Dyne_tx 2025-10-06T22:05Z 1250 followers, XXX engagements
"Next week well be at #WMS2025 to highlight data demonstrating the potential of our therapies to address the underlying causes of neuromuscular diseases to provide functional improvement. See the program and visit us at our booth:"
X Link @Dyne_tx 2025-10-03T18:48Z 1249 followers, XXX engagements
"Were pleased to welcome Brian Posner to Dynes Board of Directors. His 30+ years of executive and investment leadership will help guide our mission to deliver functional improvement for people living with neuromuscular diseases. Read more:"
X Link @Dyne_tx 2025-10-02T20:08Z 1250 followers, XXX engagements
"Kathleen Tregoning joined us for our FORCEs in Biotech series sharing insights on government affairs: Government affairs isnt bowlingits billiards. Every move every conversation every engagement bounces off another. Its all connected"
X Link @Dyne_tx 2025-10-15T15:32Z 1251 followers, XX engagements